In the BioHarmony Drug Report Database
Valproate sodium
Depacon (valproate sodium) is a small molecule pharmaceutical. Valproate sodium was first approved as Depacon on 1996-12-30. It is known to target histone deacetylase 1.
Trade Name
|
Depacon |
|---|---|
Common Name
|
valproate sodium |
ChEMBL ID
|
CHEMBL433 |
Indication
|
|
Drug Class
|
Image (chem structure or protein)